Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Cyproheptadine and Adrenocorticotropic Hormone

Research Papers that Mention the Interaction

Previous studies have found that bromocriptine, cyproheptadine , and valproic acid can reduce ACTH secretion in Nelson's syndrome, but none of these agents has achieved widespread use due to their failure to normalize ACTH in most patients.
The Journal of clinical endocrinology and metabolism  •  1997  |  View Paper
To further elucidate the inhibitory action of cyproheptadine on ACTH release, we studied the influence of cyproheptadine (0.1 mg/kg body weight) on the corticotropin releasing hormone (CRH)--induced hormone release in normal subjects.
Hormone and metabolic research. Supplement series  •  1987  |  View Paper
Cyproheptadine , a nonselective 5-hydroxytryptamine receptor blocking agent, reduces ACTH and ß-endorphin secretion from the ACTH-producing tumors.
Journal of endocrinological investigation  •  1996  |  View Paper
Cyproheptadine and bromocriptine have been reported to be therapeutic in suppressing ACTH levels in Cushing's disease and Nelson's syndrome.
Clinical endocrinology  •  1990  |  View Paper
Oral administration of either bromocriptine (2.5 mg) or cyproheptadine (8 mg) caused a marked drop in plasma ACTH levels.
Short-term (3-week) treatment with either bromocriptine (7.5 mg/day) or cyproheptadine (12 mg/day) resulted in a marked suppression of basal ACTH release.
Endocrinologia japonica  •  1984  |  View Paper
Cyproheptadine and reserpine (10(-9)-10(-7) M of each) suppressed immunoreactive ACTH and beta-endorphin secretion from both tissues.
The Journal of clinical endocrinology and metabolism  •  1983  |  View Paper
These results support the view that cyproheptadine may exert an inhibitory effect on ACTH secretion in subjects whose corticosteroid feedback mechanism is normal.
Acta endocrinologica  •  1983  |  View Paper
Somatostatin, dexamethasone, bromocriptine, and cyproheptadine in a concentration of 1 microM each inhibited ACTH release by 25 +/- 2%, 35 +/- 2%, 52 +/- 2%, and 61 +/- 4%, respectively, while lysine vasopressin (0.1 microM) and dibutyryl cAMP (5 mM) stimulated ACTH release by 112 +/- 8% and 220 +/- 4%, respectively.
The Journal of clinical endocrinology and metabolism  •  1981  |  View Paper
Administration of cyproheptadine caused a dramatic fall in urinary cortisol excretion and plasma ACTH levels associated with clinical remission of the Cushing's syndrome.
The Journal of clinical endocrinology and metabolism  •  1981  |  View Paper
Incubation of cells with cyproheptadine (1 or 0.1 microM) resulted in a significant decrease in ACTH release, and inhibited stimulation produced by TRH in one experiment.
The Journal of clinical investigation  •  1981  |  View Paper
Show More